Drug Trial Radar · NCT01922037
A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair)
Last checked: Nov 20, 2026Latest source record: Dec 11, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
806
Actual
Start
Jun 19, 2013
Primary completion
Mar 31, 2016
Study completion Mar 31, 2016
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Aug 14, 2013
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This multicenter, prospective study will evaluate the baseline participant characteristics (including biomarkers) associated with a variety of individual and composite clinical outcomes in participants with moderate to severe asthma initiating treatment with omalizumab.
Conditions
- Asthma
Interventions
OmalizumabDrug
Participants will receive omalizumab for up to 12 months per investigator standard of care and clinical practice.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Total Number of Asthma Exacerbations During Months 1-12Time frame: Months 1-12
Locations
145 sites in 1 country. Site status is shown where the registry gives one.
Alabama Allergy & Asthma
Birmingham, Alabama
Achieve Clinical Research, LLC
Birmingham, Alabama
Huntsville Lung Associates PC
Huntsville, Alabama
San Tan Allergy & Asthma
Gilbert, Arizona
Dedicated Clinical Research
Goodyear, Arizona
Allergy Associates of Tucson
Tucson, Arizona
University of Arizona
Tucson, Arizona
Little Rock Allergy & Asthma; Clinical Research Center
Little Rock, Arkansas
Stuart Epstein MD - PP
Beverly Hills, California
West Coast Clinical Trials Global, LLC
Costa Mesa, California
Peninsula Allergy Associates
Daly City, California
Allianz Medical and Research Center
Fountain Valley, California
William Ebbeling MD - PP
Fresno, California
Gettysburg Medical Clinic
Fresno, California
Allergy & Asthma Inst Valley
Granada Hills, California
VA Loma Linda Healthcare System
Loma Linda, California
Allergy Asthma Care Ctr, Inc.
Los Angeles, California
Southern California Research Center
Mission Viejo, California
North Bay Allergy & Asthma; Medical Assoc
Napa, California
Choc Psf, Amc
Orange, California
Clinical Trials of Orange County
Orange, California
California Allergy & Asthma Medical Group, Inc.
Palmdale, California
Joann Blessing-Moore MD - PP
Palo Alto, California
TPMG - Rancho Cordova
Rancho Cordova, California
Redding Allergy & Asthma Care
Redding, California
Allergy & Asthma Consultants
Redwood City, California
Capital Allergy Resp Dis Ctr
Sacramento, California
Central Coast Allergy and Asthma
Salinas, California
Allergy Assoc Medical Group
San Diego, California
Kaiser Permanente - San Diego
San Diego, California
University of California at San Francisco
San Francisco, California
Asthma & Allergy Clinic
San Francisco, California
The Allergy and Asthma Clinic
San Mateo, California
Allergy & Asthma Medical Group; Clinical Research Division
Walnut Creek, California
IMMUNOe International Research Centers
Centennial, Colorado
Danbury Hospital
Danbury, Connecticut
Christopher C Randolph MD - PP
Waterbury, Connecticut
Waterbury Pulmonary Associates
Waterbury, Connecticut
St. Francis Sleep; Allergy & Lung Institute
Clearwater, Florida
AAADRS; Clinical Research Center
Coral Gables, Florida
Showing 40 of 145 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.